Production of the Inaccessible Sesquiterpene (−)‐5‐Epieremophilene by Metabolically Engineered Escherichia coli

Wiley - Tập 17 Số 7 - 2020
Liu‐Qiong Luo1,2, Yue‐Gui Chen1,2, Desen Li1,2, Yan Liu1, Sheng‐Hong Li1
1State Key Laboratory of Phytochemistry and Plant Resources in West China and Yunnan Key Laboratory of Natural Medicinal Chemistry, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, P. R. China
2University of Chinese Academy of Sciences, Beijing 100049, P.R. China

Tóm tắt

Abstract(−)‐5‐Epieremophilene, an epimer of the versatile sesquiterpene (+)‐valencene, is an inaccessible natural product catalyzed by three sesquiterpene synthases (SmSTPSs1‐3) of the Chinese medicinal herb Salvia miltiorrhiza, and its biological activity remains less explored. In this study, three metabolically engineered Escherichia coli strains were constructed for (−)‐5‐epieremophilene production with yields of 42.4–76.0 mg/L in shake‐flask culture. Introducing an additional copy of farnesyl diphosphate synthase (FDPS) gene through fusion expression of SmSTPS1‐FDPS or dividing the FDP synthetic pathway into two modules resulted in significantly improved production, and ultimately 250 mg of (−)‐5‐epieremophilene were achieved. Biological assay indicated that (−)‐5‐epieremophilene showed significant antifeedant activity against Helicoverpa armigera (EC50=1.25 μg/cm2), a common pest of S. miltiorrhiza, implying its potential defensive role in the plant. The results provided an ideal material supply for studying other potential biological activities of (−)‐5‐epieremophilene, and also a strategy for manipulating terpene production in engineered E. coli using synthetic biology.

Từ khóa


Tài liệu tham khảo

10.1021/acs.chemrev.7b00287

10.1038/nchembio.2007.5

10.1055/a-0953-6738

10.1105/tpc.15.00715

10.1093/jxb/err466

10.1016/j.phytochem.2019.03.009

10.1016/bs.mie.2018.05.004

10.1126/science.1191652

10.1073/pnas.1705567114

10.1002/anie.201711444

10.1002/ange.201711444

10.3390/ijms140612780

10.1002/anie.201601967

10.1002/ange.201601967

10.1021/jf011456i

R. H. Leonhardt R. G. Berger in ‘Biotechnology of isoprenoids nootkatone’ Eds. J. Schrader and J. Bohlmann Springer International Publishing Cham 2015 pp. 391–404.

10.1016/j.fct.2009.11.008

10.1038/nature12051

10.1016/j.ymben.2011.08.001

10.1016/j.bej.2018.05.023

10.3389/fpls.2017.00627

Chinese Pharmacopoeia Commission ‘Pharmacopoeia of the People's Republic of China’ China Medical Science Press Beijing 2015 pp. 76–77.

10.1021/cr200058f

10.1016/j.jbiotec.2014.05.032

10.1021/acs.jnatprod.5b01127

10.1186/s12934-019-1246-2

10.1007/s00253-014-5581-2

10.1002/biot.201400288

10.1038/ncomms1494

10.1016/j.tibtech.2019.11.007

10.1038/s41467-018-04211-x

10.1038/s41467-019-09848-w

10.1016/0378-1119(95)00584-1

Thông tin
Thông tin xuất bản

Wiley

Tập 17 Số 7

Thông tin tác giả